Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD?

Respirology

Volumn 9, Issue 3, 2004, Pages 352-355

  Yildiz, Fusun ^a,b   Basyigit, Ilknur ^a   Yildirim, Elif ^a   Boyaci, Hasim ^a   Ilgazli, Ahmet ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

COPD; Inhaled corticosteroid; Quality of life; St George's Respiratory Questionnaire

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; PLACEBO; STEROID;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; HEALTH STATUS; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; BUDESONIDE; CARBON DIOXIDE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 6044257736     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2004.00618.x     Document Type: Article

References (20)

1. NHLBI/WHO Workshop Report. Global Strategy for Asthma Management and Prevention. NHLBI/WHO, Bethesda, MD, 1995 (Revised 2002).
2. van Rensen ELJ, Straathof KCM, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 1999; 54: 403-8.
3. Yildiz F, Kaur AC, Ilgazli A et al. Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease. Respiration 2000; 67: 71-6.
4. Thompson WH, Carvalho P, Souza JP, Charan NB. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD. Lung 2002; 180: 191-201.
5. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 1997; 155: 542-8.
6. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-7.
7. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir. Med. 1991; 85 (Suppl. B): 25-31.
8. Rutten-van Mölken M, Roos B, Van Noord JA. An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999; 54: 995-1003.
9. Gallefoss F, Bakke PS, Kjaersgaard P. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 812-7.
10. Domingo-Salvany A, Lamarca R, Ferrer M et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2002; 166: 680-5.
11. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am. J. Respir. Crit. Care Med. 1997; 155: 1283-9.
12. Donohue JF, Van Noord JA, Bateman ED et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.
13. Dahl R, Greefhorst LA, Nowak D et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 778-84.
14. O'Brien A, Russo-Magno P, Karki A et al. Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction. Am. J. Respir. Crit. Care Med. 2001; 164: 365-71.
15. van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am. J. Respir. Crit. Care Med. 2002; 166: 1358-63.
16. Spencer S, Calverley PMA, Burge PS, Jones PW, ISOLDE Study Group. Inhaled Steroids in Obstructive Lung Disease. Health status deterioration in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 163: 122-8.
17. Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA, Maslen TK, on behalf of the ISOLDE study investigators. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000; 320: 1297-303.
18. Szafranski W, Cukier A, Ramirez A et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 21: 74-81.
19. Bourbeau J, Rouleau MY, Boucher S. Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Thorax 1998; 53: 477-82.
20. van Schayck CP, Dompeling E, Rutten MP, Folgering H, van den Boom G, van Weel C. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995; 107: 1199-205.